An early Phase II clinical trial of BW234U in the treatment of acute schizophrenia in newly admitted patients-Reference-Cited by-同舟云学术

An early Phase II clinical trial of BW234U in the treatment of acute schizophrenia in newly admitted patients

Published:1984-10 Issue:2 Volume:84 Page:282-284
ISSN:0033-3158
Container-title:Psychopharmacology
language:en
Short-container-title:Psychopharmacology

Author:

Chouinard G.,Annable L.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology

Link

http://link.springer.com/content/pdf/10.1007/BF00427460.pdf

Reference11 articles.

1. American Psychiatric Association (1980) Diagnostic and statistical manual of mental disorders (DSM-III). Washington DC

2. Burroughs Wellcome Company (June 1983) Clinical Investigator's Manual, BW234U

3. Chouinard G, Annable L, Loss-Chouinard A, Kropsky M (1979) Ethopropazine and benztropine in neuroleptic-induced parkinsonism. J Clin Psychiatry 40:73?81

4. Chouinard G, Ross-Chouinard A, Annable L, Jones BD (1980) Extrapyramidal symptom rating scale. Can J Neurol Sci 7:233

5. Creese I, Snyder SH (1977) A simple and sensitive radioreceptor assay for antischizophrenic drugs in blood. Nature 270:180?182

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sigma 1 Receptor Chaperone: Pharmacology and Therapeutic Perspectives;Therapeutic Targets;2012-05-29

2. Targeting ligand-operated chaperone sigma-1 receptors in the treatment of neuropsychiatric disorders;Expert Opinion on Therapeutic Targets;2011-03-05

3. Review of the Pharmacological and Clinical Profile of Rimcazole;CNS Drug Reviews;2006-06-07

4. The Antipsychotic Effects of Sigma Drugs;Neurotransmitter Receptors in Actions of Antipsychotic Medications;2000-06-22

5. Polymorphisms of the ?1 receptor gene in schizophrenia: An association study;American Journal of Medical Genetics;2000-02-07